Coherus Oncology Inc (CHRS) USD0.0001

Sell:$1.47Buy:$1.64Price decreased$0.07 (4.46%)

NASDAQ:Price decreased0.51%
Market closed |
Prices delayed by at least 15 minutes
Sell:$1.47
Buy:$1.64
Change:Price decreased$0.07 (4.46%)
Deal now
Market closed |
Prices delayed by at least 15 minutes
Sell:$1.47
Buy:$1.64
Change:Price decreased$0.07 (4.46%)
Market closed |
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open$1.57
Previous close$1.57
Market cap$242.17m
P/E ratio-
Volume420,118
Dividend yield0.00%
EMS-

Company information

Coherus Oncology, Inc., formerly Coherus BioSciences, Inc., is a fully integrated commercial-stage oncology company with an approved PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue154.25m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.